Beta-Blocker Evaluation in Survival Trial (BEST)

NCT00000560 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cardiovascular Diseases
Heart Diseases
Heart Failure, Congestive
Heart Failure

Interventions

DRUG: adrenergic beta antagonists

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)